|
|
|
|
|
|
|
|
 |
|
 |
Une liste des échantillons des programmes d’EEQ disponibles à QCMD est affichée ci-dessous. Pour plus d’informations ou pour s’inscrire à un quelconque programme d’EEQ, connectez-vous à votre plate-forme virtuelle QCMD.
Si vous n’avez pas de nom d’utilisateur et de mot de passe, cliquez ici. |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| HIV-1 (DNA)
|
|
Qualitative |
Dry-ice
|
| B19 Virus
|
|
Qualitative & Quantitative
|
Dry-ice
|
| HCV Genotyping
|
|
Molecular Typing
|
Dry-ice
|
| HBV Genotyping
|
 |
Molecular Typing |
Dry-ice |
| HIV-1 Drug Resistance
|
 |
Sequencing
|
Ambient |
| HIV-1 Drug Resistance (Integrase)
|
 |
Sequencing |
Ambient
|
| Hepatitis A virus
|
|
Qualitative & Quantitative
|
Dry-ice |
| Hepatitis E virus
|
|
Qualitative & Quantitative
|
Dry-ice |
| HBV Drug Resistance
|
 |
Sequencing |
Dry-ice
|
| HCV Drug Resistance
|
 |
Sequencing |
Dry-ice
|
| HIV-1 (RNA)
|
|
Qualitative & Quantitative
|
Dry-ice
|
| HIV-1 RNA regulatory programme
|
|
Qualitative & Quantitative
|
Dry-ice
|
| Hepatitis B virus
|
|
Qualitative & Quantitative
|
Dry-ice |
| HBV regulatory programme
|
|
Qualitative & Quantitative |
Dry-ice
|
| Hepatitis C virus
|
|
Qualitative & Quantitative
|
Dry-ice
|
| HCV regulatory programme
|
|
Qualitative & Quantitative
|
Dry-ice |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| Varicella-Zoster virus
|
|
Qualitative & Quantitative
|
Ambient |
| Enterovirus
|
|
Qualitative & Quantitative |
Ambient |
| Parechovirus
|
|
Qualitative & Quantitative |
Ambient
|
| Herpes simplex virus 1 & 2
|
 |
Qualitative & Quantitative |
Ambient
|
| West Nile Virus
|
 |
Qualitative |
Ambient
|
| Dengue Virus
|
 |
Qualitative |
Ambient
|
| JC virus and BK virus
|
 |
Qualitative & Quantitative |
Dry-ice |
| Toxoplasma gondii
|
 |
Qualitative |
Ambient
|
| Borrelia burgdorferi (Lyme's disease)
|
|
Qualitative |
Dry-ice |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| Cytomegalovirus Dried Blood Spots
|
|
Qualitative & Quantitative
|
Dry-ice
|
| Toxoplasma gondii
|
 |
Qualitative
|
Ambient
|
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| Methicillin Resistant S. aureus
|
|
Qualitative
|
Ambient
|
| HIV-1 Drug Resistance
|
 |
Sequencing
|
Ambient |
| HIV-1 Drug Resistance (Integrase) |
 |
Sequencing |
Ambient |
| Extended Spectrum ß-lactamase |
|
Qualitative |
Dry-ice |
| Vancomycin Resistant Enterococci |
|
Qualitative |
Dry-ice |
| Methicillin Resistant S. aureus SPA |
 |
Sequencing |
Dry-ice |
| HBV Drug Resistance |
 |
Sequencing |
Dry-ice |
| HCV Drug Resistance
|
 |
Sequencing |
Dry-ice
|
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| West Nile Virus |
 |
Qualitative
|
Ambient
|
| Dengue Virus
|
|
Qualitative |
Ambient |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| Clostridium difficile |
|
Qualitative |
Ambient |
| Adenovirus |
 |
Qualitative & Quantitative |
Dry-ice |
| Norovirus |
|
Qualitative |
Dry-ice |
| Viral Gastroenteritis |
|
Qualitative |
Dry-ice |
| Bacterial Gastroenteritis |
|
Qualitative |
Dry-ice |
| Parasitic Gastroenteritis
|
|
Qualitative
|
Dry-ice |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| JC virus and BK virus |
 |
Qualitative & Quantitative |
Dry-ice |
| Human Herpes Virus 6 |
 |
Qualitative & Quantitative |
Dry-ice |
| Human Cytomegalovirus |
 |
Qualitative & Quantitative |
Dry-ice |
| Human Cytomegalovirus Whole Blood |
 |
Qualitative & Quantitative |
Dry-ice |
| Epstein-Barr virus |
 |
Qualitative & Quantitative |
Dry-ice |
| Epstein-Barr virus Whole Blood
|
 |
Qualitative & Quantitative |
Dry-ice |
| Toxoplasma gondii |
 |
Qualitative |
Ambient |
| Aspergillus |
|
Qualitative |
Dry-ice |
| Candida spp |
|
Qualitative |
Dry-ice |
| Pneumocystis jirovecii pneumonia (PCP) |
 |
Qualitative
|
Dry-ice |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
Chlamydophila pneumoniae and
Mycoplasma pneumoniae |
|
Qualitative |
Ambient |
| Legionella pneumophila |
|
Qualitative |
Ambient |
| M. tuberculosis Complex |
|
Qualitative |
Ambient |
| Bordetella pertussis |
|
Qualitative & Quantitative |
Dry-ice |
| Adenovirus |
 |
Qualitative & Quantitative |
Dry-ice |
| Influenza A & B virus
|
|
Qualitative |
Dry-ice |
| Human Metapneumovirus |
|
Qualitative |
Dry-ice |
| Respiratory Syncytial Virus |
|
Qualitative |
Dry-ice |
| Parainfluenza virus |
|
Qualitative |
Dry-ice |
| Coronavirus |
|
Qualitative |
Dry-ice |
| Rhinovirus |
|
Qualitative |
Dry-ice |
| Influenza Haemagglutinin Typing |
 |
Molecular typing |
Dry-ice |
| Chlamydia psittaci |
|
Qualitative |
Dry-ice |
| Pneumocystis jirovecii pneumonia (PCP) |
 |
Qualitative
|
Dry-ice |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| Chlamydia trachomatis |
|
Qualitative |
Ambient |
| Herpes simplex virus 1 & 2 |
 |
Qualitative & Quantitative |
Ambient |
| Neisseria gonorrhoeae |
|
Qualitative |
Ambient |
| Human Papillomavirus |
|
Qualitative |
Ambient |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| JC virus and BK virus |
 |
Qualitative & Quantitative |
Dry-ice |
| Human Herpes Virus 6 |
 |
Qualitative & Quantitative |
Dry-ice |
| Human Cytomegalovirus |
 |
Qualitative & Quantitative |
Dry-ice |
| Human Cytomegalovirus Whole Blood |
 |
Qualitative & Quantitative |
Dry-ice |
| Epstein-Barr virus |
 |
Qualitative & Quantitative |
Dry-ice |
| Epstein-Barr virus Whole Blood |
 |
Qualitative & Quantitative |
Dry-ice |
| Toxoplasma gondii |
 |
Qualitative |
Ambient |
| Adenovirus |
 |
Qualitative & Quantitative |
Dry-ice |
|
|
EQA Programme
|
|
Analysis Type
|
Shipping Conditions
|
| HCV Genotyping |
 |
Molecular Typing |
Dry-ice |
| HBV Genotyping |
 |
Molecular Typing |
Dry-ice |
| Methicillin Resistant S. Aureus Typing |
|
Molecular Typing |
Ambient |
| HIV-1 Drug Resistance |
 |
Sequencing |
Ambient |
| HIV-1 Drug Resistance (Integrase) |
 |
Sequencing |
Ambient |
| Methicillin Resistant S. aureus SPA |
 |
Qualitative |
Dry-ice |
| HBV Drug Resistance |
 |
Sequencing |
Dry-ice |
| HCV Drug Resistance |
 |
Sequencing |
Dry-ice |
| Influenza Haemagglutinin Typing |
 |
Molecular Typing |
Dry-ice |
| MALDI-TOF Bacterial |
|
Qualitative |
Dry-ice |
|
|
|
 |
|
 |
Unit 5, Technology
Terrace, Todd Campus, West of Scotland Science Park Glasgow
G20 0XA Scotland, UK
Tel: +44 (0)141 945 6474 Fax:
+44 (0)141 945 5795 Contact Us
|
|
|
|
|